Skip to Content

Join the 'Signifor' group to help and get support from people like you.

Signifor News

Novartis Gains FDA Approval for Signifor LAR to Treat Patients with Acromegaly

Posted 16 Dec 2014 by

EAST HANOVER, N.J., Dec. 16, 2014 Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor long-acting release (LAR)* (pasireotide) for injectable suspension, for intramuscular use, for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. The approval of Signifor LAR, a ...

Ask a Question

Further Information

Related Condition Support Groups

Cushing's Syndrome

Signifor Patient Information at